CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 60

Industry reads hand-picked by our editors

Mar 05, 2024

Forbes
Does Federally Funded Research Justify A Piece Of Pharma’s Profits?
The Wall Street Journal
Novo Nordisk Says Ozempic Drug Cuts Risk of Kidney Problems
Politico
White House turns to health care in Biden’s latest move against ‘corporate greed’

Mar 04, 2024

Bloomberg
The Dirty Business of Monkey Laundering
Axios
Weight-loss drug restrictions shine spotlight on imbalance in obesity care
The Boston Globe
‘It’s a nightmare’: One of the most common children’s asthma meds is no longer available, leaving families scrambling

Mar 01, 2024

Bloomberg
Obesity Drugs Won’t Solve Problem That Affects 1 Billion People, WHO Warns
Financial Times
Lab monkey prices plunge in China as drug research slows
Science
‘A tough experience.’ Why would a scientist serve as an expert witness?

Feb 29, 2024

Stat
An inside look at PIPEs, biotech’s buzzy new financing tool
Science
Why are all proteins ‘left-handed’? New theory could solve origin of life mystery
Reuters
Sandoz enters $265 million settlement agreement in U.S. price-fixing case
C&EN
Hey, chatbot, can you synthesize this molecule?

Feb 28, 2024

Bloomberg
US Data Security Order To Limit China’s Access to Americans’ Personal Data
MIT Technology Review
Tackling long-haul diseases
Fierce Biotech
AbbVie pays $48M for OSE’s preclinical chronic inflammation drug

Feb 27, 2024

Reuters
Bristol Myers CEO says India to have largest R&D presence outside US by 2025
Endpoints News
Failure, faith and $8 billion: How Lilly’s amyloid conviction brought it to the brink of Alzheimer’s approval
Axios
Congress eyes narrow health package

Feb 26, 2024

Fierce Biotech
J&J to close Bay Area R&D site less than 18 months after opening
The Denver Post
Enbrel price cap OK’d by Colorado Prescription Drug Affordability Board
The Pharma Letter
FDA issues final decision to withdraw Pepaxto accelerated approval
The New York Times
Drug Drastically Reduces Children’s Reactions to Traces of Food Allergens

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
Structuring Unstructured Data for the Next Generation of Complex Trials Custom content for IMO Health
Trendline
The state of vaccine development in pharma Supported by Thermo Fisher Scientific
Trendline
The latest developments in oncology research Supported by CG Life

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
4 major trends shaping today’s oncology market Webinar - on demand • Provided by Advisory Board
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.